Fcf Advisors LLC Gilead Sciences, Inc. Transaction History

Fcf Advisors LLC

$619 Million
Q1 2025

A detailed history of Fcf Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Fcf Advisors LLC holds 162,186 shares of GILD stock, worth $16.7 Million. This represents 2.94% of its overall portfolio holdings.

Number of Shares

162,186

Previous 125,877 28.84%

Holding current value

$16.7 Million

Previous $11.6 Million 56.29%

% of portfolio

2.94%

Previous 1.82%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 15, 2025	BUY	$89.14 - $117.41 $3.24 Million - $4.26 Million	36,309 Added 28.84%	162,186 $18.2 Million
Q4 2024 Feb 13, 2025	BUY	$83.95 - $97.9 $4.23 Million - $4.93 Million	50,408 Added 66.79%	125,877 $11.6 Million
Q3 2024 Oct 08, 2024	BUY	$66.59 - $83.99 $388,685 - $490,249	5,837 Added 8.38%	75,469 $6.33 Million
Q2 2024 Jul 18, 2024	BUY	$63.15 - $72.88 $426,199 - $491,867	6,749 Added 10.73%	69,632 $4.78 Million
Q1 2024 Apr 12, 2024	BUY	$71.58 - $87.29 $363,411 - $443,171	5,077 Added 8.78%	62,883 $4.61 Million
Q4 2023 Jan 04, 2024	BUY	$73.27 - $83.09 $2.52 Million - $2.85 Million	34,349 Added 146.43%	57,806 $4.68 Million
Q3 2023 Oct 10, 2023	SELL	$73.94 - $80.67 $46,951 - $51,225	-635 Reduced 2.64%	23,457 $1.76 Million
Q2 2023 Jul 19, 2023	SELL	$76.01 - $86.7 $12,009 - $13,698	-158 Reduced 0.65%	24,092 $1.86 Million
Q1 2023 Apr 19, 2023	BUY	$77.31 - $88.08 $822,037 - $936,554	10,633 Added 78.09%	24,250 $2.01 Million
Q4 2022 Feb 03, 2023	SELL	$62.32 - $89.47 $19,069 - $27,377	-306 Reduced 2.2%	13,617 $1.17 Million
Q3 2022 Oct 12, 2022	SELL	$59.54 - $68.01 $60,730 - $69,370	-1,020 Reduced 6.83%	13,923 $858,000
Q2 2022 Jul 20, 2022	SELL	$57.72 - $65.01 $515,843 - $580,994	-8,937 Reduced 37.42%	14,943 $924,000
Q1 2022 Apr 28, 2022	BUY	$57.92 - $72.58 $1.38 Million - $1.73 Million	23,880 New	23,880 $1.42 Million
Q4 2020 Jan 12, 2021	SELL	$56.65 - $64.55 $1.53 Million - $1.74 Million	-27,033 Closed	0 $0
Q3 2020 Oct 20, 2020	BUY	$62.1 - $78.08 $602,494 - $757,532	9,702 Added 55.98%	27,033 $1.73 Million
Q2 2020 Jul 10, 2020	SELL	$72.34 - $84.0 $55,701 - $64,680	-770 Reduced 4.25%	17,331 $1.32 Million
Q1 2020 Apr 21, 2020	BUY	$62.63 - $80.22 $1.13 Million - $1.45 Million	18,101 New	18,101 $1.32 Million

Others Institutions Holding GILD

# of Institutions

2,146

Shares Held

988M

Call Options Held

8.73M

Put Options Held

9.63M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $129B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fcf Advisors LLC with notifications on news.

Account